Background Obstructive sleep apnoea (OSA) is a wellrecognised complication of obesity. Non-surgical weight loss (medical, behavioural and lifestyle interventions) may improve OSA outcomes, although long-term weight control remains challenging. Bariatric surgery offers a successful strategy for long-term weight loss and symptom resolution. Objectives To comparatively appraise bariatric surgery vs. non-surgical weight loss interventions in OSA treatment utilising body mass index (BMI) and apnoea-hypopnoea index (AHI) as objective measures of weight loss and apnoea severity. Methods A systematic literature review revealed 19 surgical (n=525) and 20 non-surgical (n=825) studies reporting the primary endpoints of BMI and AHI before and after intervention. Data were meta-analysed using random effects modelling. Subgroup analysis, quality scoring and risk of bias were assessed. Results Surgical patients had a mean pre-intervention BMI of 51.3 and achieved a significant 14 kg/m 2 weighted decrease in BMI (95%CI [11.91, 16.44 Conclusions Both bariatric surgery and non-surgical weight loss may have significant beneficial effects on OSA through BMI and AHI reduction. However, bariatric surgery may offer markedly greater improvement in BMI and AHI than nonsurgical alternatives. Future studies must address the lack of randomised controlled and comparative trials in order to confirm the exact relationship between metabolic surgery and non-surgical weight loss interventions in OSA resolution.
Introduction
The global prevalence of obesity is increasing with the World Health Organization estimating that 11 % of adults are obese worldwide [1] . Alongside this increase in obesity is a continuous rise in the incidence of obstructive sleep apnoea (OSA), which is now thought to affect at least 100 million adults [2] . OSA is characterised by repeated periods of complete or partial upper airway collapse during sleep, resulting in episodes of apnoea and hypopnoea. Severe OSA is indicated by polysomnographic measurement of over 30 obstructive apnoea and hypopnoea episodes per hour of sleep (an apnoeahypopnoea index (AHI) of >30) [3] . In such severe cases, OSA may be complicated by hypertension, cardiovascular disease, stroke and excessive daytime sleepiness, as well as a diminished quality of life, decreased cognitive function and elevated risk of motor vehicle accidents [4] . Obesity accounts for up to 58 % of adult OSA cases [5] , with evidence from the Wisconsin Sleep Cohort Study suggesting that relative to stable weight individuals with a 10 % increase in body weight have a sixfold elevated risk of developing moderate-to-severe OSA.
Continuous positive airway pressure (CPAP) is an established symptomatic therapy for OSA; however, it may cause skin irritation, airway dryness, claustrophobia and general discomfort leading to reduced patient compliance [6] . As a result, lifestyle weight loss interventions such as exercise promotion, dietary modification, pharmacotherapy and behavioural therapy are therefore increasingly recommended as alternatives or adjuncts to CPAP [7, 8] within the context of established OSA treatments (such as otolaryngologic surgery that addresses the tonsils, base of tongue, epiglottis and pharynx). However, although these weight loss therapies may improve both OSA outcomes and the metabolic sequela of obesity, long-term weight control and consequently OSA resolution remain challenging.
Bariatric surgery offers an alternative method of maintaining long-term weight reduction and improving OSA outcomes whilst at the same time improving glycaemic control and reducing cardiovascular and cancer risk [9] . Indeed, a recent systematic review demonstrated that over 75 % of patients receiving bariatric surgery demonstrated some improvement in OSA outcomes [10] . However, although there is evidence to suggest both bariatric surgical and non-surgical, interventions may improve OSA outcomes through weight reduction, and there is a paucity of studies directly comparing these treatment strategies. This study therefore aims to systematically review and meta-analyse the current evidence to concurrently appraise bariatric surgery and non-surgical weight loss interventions in the treatment of OSA, through the assessment of AHI and body mass index (BMI) as summary outcome parameters.
Methods

Literature Search
A literature search was performed using PubMed, Ovid, Embase and Cochrane databases using combinations of the terms 'sleep apnoea', 'obstructive sleep apnoea', and 'weight loss', 'weight reduction', 'bariatric surgery'. The 'related articles' function in PubMed was used as a further check of rigor. The last date for this search was 25 July 2013. The search strategy is outlined in Fig. 1 . All studies have been listed in Table 1 (bariatric surgery) and Table 2 (non-surgical weight loss management) to offer an overview of the appraised literature in addition to identifying the proportion that offer both outcomes of BMI and AHI.
Inclusion and Exclusion Criteria
All studies reporting body mass index (BMI) and apnoeahypopnoea index (AHI) before and after either (a) bariatric surgery or (b) non-surgical weight loss intervention were included. Studies were excluded from the review if (1) inconsistency of data did not allow valid extraction, (2) studies did not report both AHI and BMI, (3) they reported sleep study and other polysomnographic measures that did not include AHI (e.g. respiratory disturbance index (RDI) which is similar but not interchangeable with AHI), (4) data was duplicated, (5) the trial was carried out on animal models, and (6) English language full text was not available.
Based on these criteria, two assessors (HA and SR) independently selected studies for further examination by title and abstract review. All potentially eligible studies were retrieved in full for further evaluation. Any disagreement was resolved by discussion with the senior author.
Data Analysis
Two authors (HA and SR) independently extracted the following data from each paper using a standardised spreadsheet: first author, year of publication, study type, number of subjects and study population demographics. Specific outcome data was retrieved for the following: (i) apnoea-hypopnoea index (AHI) and (ii) BMI.
Meta-analysis was performed in line with recommendations from the Cochrane Collaboration and in accordance with both Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines [11, 12] . Analysis was conducted by use of Review Manager® Version 5.3.4 for Windows (The Cochrane Collaboration, Software Update, Oxford, UK) and STATA v.12 statistical analysis software.
Data was analysed using a random effects model. Continuous data were investigated using weighted mean difference (WMD) as the summary statistic, reported with 95 % confidence intervals (CI). The point estimate of the WMD was considered statistically significant at p<0.05, if the 95 % confidence interval did not include the value zero. Categorical variables were analysed using the odds ratio (OR). An OR of <1 favoured the treatment group, and the point estimate of the OR is considered statistically significant at the p<0.05 level, if the 95%CI does not include the value 1.
Heterogeneity
Inter-study heterogeneity was explored using the χ 2 -statistic, but I 2 was calculated to quantify the degree of heterogeneity across trials that could not be attributable to chance alone. When I 2 was >50 %, significant statistical heterogeneity was considered to be present.
Three strategies were used to assess data validity and heterogeneity: (1) sensitivity analysis of higher quality studies (quality score >7), (2) funnel plots to evaluate publication bias and (3) assessment of publication bias using Egger's test for small-study effects.
Quality Scoring
Quality assessment of each study was performed by attributing a quality assessment score using a modification of the Newcastle-Ottawa scale [11] . Studies attaining greater than the median score of 7 (out of a maximum 15) were defined to have 'higher matching quality' and were included in subgroup analysis. Modified Newcastle-Ottawa scoring criteria are shown in the Supplementary Appendix: Table 2 .
Results
Surgical Group Nineteen studies [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] fulfilled the inclusion criteria, producing a pooled data set of 525 patients with obstructive sleep apnoea (OSA) undergoing bariatric surgery (Table 1 -listing bariatric surgical studies on OSA outcomes). Fifteen of these were nonrandomised, prospective observational studies [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] , three were retrospective cohort studies [24, 25] , and one was a prospective randomised controlled trial [26] . One study [23] compared the effect of two surgical modalities on OSA. Each of these groups was considered independently in the following analysis.
Non-Surgical Group Twenty studies [17, 21, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] fulfilled the inclusion criteria, producing a pooled data set of 825 patients with obstructive sleep apnoea (OSA) undergoing non-surgical therapies ( Table 2 -listing non-surgical studies on OSA outcomes). Thirteen were non-randomised, prospective observational studies [17, 21, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] 41] , and seven were randomised controlled trials (RCT) [26, 27, 38, 39] , of which one was multicenter [38] . Two studies [38] compared the effect of two non-surgical modalities on OSA. Each of these Charuzi [62] RYGB, VBG (Fig. 3b) .
Quality Scoring and Sensitivity Analysis
The overall quality of studies is outlined in the Supplementary Appendix: Table 2 . Subgroup results may be compared with results from the overall analysis in Table 3 .
Surgical Group
Of the 19 studies included in the surgical group, 3 were considered to be of high quality [17, 23, 26] , scoring above or equal to the median of 7. One study [23] compared the effect of two surgical modalities on OSA, and as with the overall analysis, each of these groups was considered independently.
Analysis of high-quality studies again demonstrated a reduction in both AHI (WMD 26 CPAP continuous positive airway pressure, NS not specified a Studies reporting the post-intervention changes of both body mass index (BMI) and apnoea-hypopnoea index (AHI) which were subsequently included in the analysis to derive the weighted mean change of BMI and AHI
Heterogeneity Assessment: Bias Exploration
Funnel plots were used to assess for publication bias (Supplementary Appendix: Fig. 1 ). Visual inspection revealed no funnel plot asymmetry, and Egger's test revealed no significant small study effects (Supplementary Appendix: Table 3) for either AHI or BMI outcomes.
Discussion
In 525 subjects with a mean pre-intervention BMI of 51.3, bariatric surgery offered a weighted decrease of BMI by 14 kg/m 2 and a weighted decrease of AHI by 29/h. Studies of patients undergoing non-surgical weight loss therapy revealed 825 subjects with a pre-intervention mean BMI of 38.3. Non-surgical weight loss intervention was associated with a weighted decrease in BMI by 3.1 kg/m 2 and a weighted decrease of AHI by 11/h. This study offers the first available means to objectively compare the effects of surgical and non-surgical weight loss strategies on BMI and sleep apnoea severity (measured through AHI). Although due to the lack of comparative trial data bariatric and non-surgical patients that differed in their baseline characteristics, both the weight loss effects of surgery (BMI reduction) and improvements in OSA severity (AHI reduction) were found to be greater in surgical studies (Table 2 vs. Table 3 ). Although cursory review may suggest that for each unit of BMI decrease, non-surgical treatment may offer more efficient changes in AHI score, the lack of direct comparative trials precludes this conclusion from this analysis. However, the analysis of high-quality studies significantly reduced inter-study heterogeneity and also revealed similar results favouring a robustly stronger decrease in both AHI and BMI with bariatric surgery when compared to non-surgical weight loss strategies. Bariatric surgery is now considered the most efficacious treatment for morbid obesity, reflected by over 340,000 metabolic operations performed annually [42] . The mechanisms through which these procedures may alleviate OSA have been previously summarised in the BRAVE effects, consisting of bile flow alteration, reduction of gastric size, anatomical gut rearrangement, vagal manipulation and enteric gut hormone modulation in addition to a post-operative modulation of eating behaviour and possibly improved lifestyle and exercise activity [43] . Whilst these effects likely contribute to OSA improvement through a myriad of downstream targeted metabolic effectors that act as drivers of weight loss, their actions on systemic metabolism (including those on insulin resistance and diabetes) may also reduce OSA burden through the metabolic drivers of OSA aetiology. Furthermore, surgically induced weight loss can also relieve excess pressure on the neck, diaphragm and upper airways, restoring functional residual capacity and resolving the alterations in the upper airway structure that predispose airway collapse [5, 44] .
There is accumulating evidence that OSA results as a manifestation of metabolic syndrome. Indeed, when adjusted for age, BMI, smoking and alcohol consumption, OSA has been independently associated with increased systolic and diastolic blood pressure, higher fasting insulin and abnormal lipid profiles [45] . Emerging data also suggests a correlation between type 2 diabetes and OSA. In a sample of 595 males with suspected OSA, type 2 diabetes was evident not only in 30.1 % OSA patients but also in 13.9 % of non-apnoeic snorers [46] . This causation can be explained by a variety of possible mechanisms including elevated sympathetic nervous system activity and impaired glucose metabolism secondary to hypoxia. Furthermore, the chronic sleep debt resulting from OSA itself may be independently associated with perturbed glucocorticoid regulation and glucose tolerance [47] .
OSA also appears to be accompanied by the release of proinflammatory adipokines. Patients with OSA demonstrate elevated plasma levels of interleukin (IL)-6 and tumour necrosis factor-alpha (TNF-α), as well as the inflammatory biomarker C-reactive protein (CRP) [48, 49] . Bariatric/ metabolic surgery may significantly reduce the concentration of both IL-6 and CRP [49] , as well as improving insulin resistance [50] . However, despite the restoration of inflammatory cytokine levels after surgical weight loss, the underlying mechanisms of this inflammatory cascade and its relation to OSA still remain elusive [51] .
An independent association between adipokines and OSA has also recently been established. Obese individuals demonstrate insensitivity to the adipocyte-derived hormone leptin, which is produced at chronically high levels. Furthermore, patients with OSA also display significantly higher levels of leptin when compared to non-OSA controls [52] . Bariatric surgery has been shown to significantly reduce serum leptin, independent to BMI (8.1±7.3 to 6.1±5.5 ng/ml, p<0.001) [53] , giving rise to a potential weight-independent mechanism for OSA resolution through modification of the regulatory mechanisms that control appetite and energy expenditure via the hypothalamic-pituitary axis.
However, despite its apparent benefits, concerns about the safety of bariatric surgery still exist, especially in the early post-operative period. Indeed, surgical complication rates, morbidity and mortality may all be increased by factors such as increasing BMI and coexisting medical conditions such as OSA [54] . Nevertheless, 30-day outcomes from a recent large observational study (n=4776) revealed a surgical mortality rate of only 0.3 %, with only 4.3 % experiencing an adverse outcome [55] . As such, the risks of bariatric surgery should be carefully weighed up against the long-term risk of severe obesity when considering the most appropriate treatment modality in these often complex patients.
Non-surgical weight loss methods also improved OSA outcomes, despite having more modest results than surgical approaches. Such strategies predominantly aimed to encourage lifestyle modifications through exercise, dietary interventions or a combination of both. Less common interventions included pharmacotherapy and behavioural counselling. The effects of these therapies have been hypothesised to range beyond simple weight reduction, with exercise acting to beneficially improve AHI through enhancement of thermogenic control, improvement in the upper airway muscle tonus and the restoration of chemoreceptor sensitivity to hypoxia [7, 56] . However, previous meta-analysis suggests that non-surgical interventions vary in effectiveness, with dietary interventions exhibiting a greater beneficial effect on both AHI and BMI than exercise alone [7] . Furthermore, although promising in the short-term, the long-term durability of therapies such as intensive dietary modification remains questionable.
Strengths and Limitations
This meta-analysis statistically appraises pooled data collected from 525 patients in 19 surgical studies and 825 patients receiving non-surgical interventions in 20 studies. However, the results presented here should be considered in the context of a number of limitations. Firstly, many of the trials included are inherently limited by their study design with only one surgical study and three non-surgical studies being randomised controlled trials. The majority of remaining trials were prospective observational studies, with three studies reporting data retrospectively.
Secondly, significant statistical heterogeneity was evident in our results, attributable to a variety of possible confounding factors. Aside from the aforementioned differences in study design, trials in both arms varied in follow-up and differed in patient demographics. There was also great variation in the year of publication, ranging from 1988 to 2014. As such, our analysis may not reflect the difference between current and older weight loss therapies, or the evolution in techniques of assessing AHI. Inconsistencies also arise in the type of intervention delivered to both surgical and non-surgical arms. Non-surgical interventions encompassed an assortment of dietary, exercise, drug or behaviour-related therapies, varying in a range of factors such as intensity, frequency of use and the adjunct use of CPAP. Similarly, surgical studies exhibited variation in follow-up and type of procedure and showed discrepancies in the surgical outcome measures assessed. Furthermore, when comparing the two meta-analytical groups, the mean starting BMI as well as sleep apnoea severity appears to be much higher in the surgical group, which may effect the overall reduction in BMI as well as degree of decrease in AHI. Other sources of bias influencing our analysis of surgical studies include ascertainment bias, treatment bias, intervention bias, differential bias and bias due to measuring BMI as a summary outcome.
Thirdly, despite offering clarification into the comparison of surgical and non-surgical studies by pooling results from both intervention types, our analysis still does not statistically quantify the difference in effect between them. Fourth, due to our selection criteria including the reporting of both BMI and AHI pre-and post-intervention, many well-conducted studies were eliminated from our study due to incomplete data (Tables 1 and 2). Therefore, our analysis is limited by the pool of patients included and might not be entirely representative of all interventions in the current literature.
Finally, we note a possible limitation in the use of AHI as the summary parameter for OSA treatment outcomes. AHI, derived from overnight polysonography tests, is accepted as the 'gold standard' measure in OSA diagnostics; however, there are uncertainties in the validity and reliability of its use. AHI is derived from the number of apnoeas and hypopnoeas that occur during a given sleep cycle; however, there appears to be a lack of standardisation across laboratories and studies in defining what criteria constitutes an apnoeic or hypopnoeic event. As a result of the varying methods of measuring AHI, discrepancies in the magnitude of AHI and therefore prevalence of OSA may exist amongst included studies [57] . Furthermore, the threshold for defining abnormal AHI was previously set at above 5 events/hour, and as such, there may be difficulties comparing OSA severity in older studies with the more current literature [58] .
Finally, within non-surgical studies, Eggers test revealed a significant small study effect when assessing pre-and postintervention BMI. A possible explanation for this is the inclusion of small samples of patients in interventions of earlier surgical studies. Furthermore, small study effects may limit the analysis through lack of power, publication bias, ascertainment bias and design bias.
Conclusion
In summary, we demonstrate that both bariatric surgery and non-surgical interventions may alleviate the burden of OSA through the reduction of BMI and AHI. However, our analysis indicates that bariatric surgery offers a markedly greater improvement in BMI and AHI, as well as the abatement of symptoms that accompany OSA. Bariatric surgery improves airway control and polysomnographic outcomes via a number of putative mechanisms. These include modification of cytokine and adipokine profiles, in addition to improved insulin resistance, altered gut hormone release and eating behaviour. Consequently, bariatric surgery can ameliorate, if not completely resolve, a number of the metabolic dysfunctions accompanying OSA including hypertension, hyperglycaemia and dyslipidemia. However, our current research is limited by a lack of randomised controlled trials and comparative studies between surgical and non-surgical interventions. Significant inter-study heterogeneity across published trials also limits out ability to conclusively determine the advantages of surgical treatment over alternative therapies. Future studies must now address the lack of randomised controlled and comparative trials that should consider post-intervention periods, response curves and the underlying mechanisms to confirm the exact relationship between metabolic surgery and non-surgical weight loss interventions in OSA resolution.
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